← Back to Search

Other

Dextrin Sulfate for AIDS

Phase 1

Waitlist Available

Research Sponsored by Steinhart Medical Associates

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Patients who have exhausted all other treatment options

Patients diagnosed with AIDS and under treatment to prevent opportunistic (AIDS-related) infection

Timeline

Screening 3 weeks

Treatment Varies

Follow Up up to 5 years

Awards & highlights

Study Summary

This trial will test the safety and effectiveness of dextrin sulfate in AIDS patients who have failed other treatments.

Who is the study for?

This trial is for HIV-positive adults with advanced AIDS who have high viral loads despite previous treatments, are currently preventing opportunistic infections, and have maintained a certain level of immune cells. They must understand the study and consent to participate. Those with active infections or conditions that could interfere with completing the study can't join.Check my eligibility

What is being tested?

The trial is testing dextrin sulfate's safety and effectiveness in patients whose AIDS has not responded to standard anti-HIV treatments. It aims to see if this drug can be an alternative for those who've exhausted other options.See study design

What are the potential side effects?

Potential side effects of dextrin sulfate may include reactions at the site of administration, gastrointestinal issues, changes in blood counts or chemistry, and possible interactions with other medications being used for HIV treatment.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I have tried all available treatments for my condition.

Select...

I have AIDS and am receiving treatment to prevent infections.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ up to 5 years

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~up to 5 years

This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 5 years for reporting.

Treatment Details

0 / 2Eligibility criteria met

Find a Location

Who is running the clinical trial?

Steinhart Medical AssociatesLead Sponsor

Media Library

Dextrin Sulfate (Other) Clinical Trial Eligibility Overview. Trial Name: NCT00004987 — Phase 1

Human Immunodeficiency Virus Infection Research Study Groups:

Human Immunodeficiency Virus Infection Clinical Trial 2023: Dextrin Sulfate Highlights & Side Effects. Trial Name: NCT00004987 — Phase 1

Dextrin Sulfate (Other) 2023 Treatment Timeline for Medical Study. Trial Name: NCT00004987 — Phase 1

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Do participants aged sixty and above meet the criteria for this investigation?

"According to the requirements for this research project, participants must fall within a certain age range. The lower limit is 18 years old and there is no upper bound."

Answered by AI

Has this course of treatment earned the endorsement of the Federal Drug Administration?

"Seeing as this is a Phase 1 trial, with limited evidence to support its safety and efficacy, our team at Power has assigned it an estimated score of 1."

Answered by AI

Does this research experiment currently have open spots for new participants?

"According to clinicaltrials.gov, this medical research is no longer accepting new participants; the study was initially posted in October 1999 and last updated on June 2005. However, there are currently 485 alternative trials that are actively recruiting candidates."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Treatment of Advanced AIDS Patients With Dextrin Sulfate

1999. "Treatment of Advanced AIDS Patients With Dextrin Sulfate". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT00004987.

All > Hiv Infection > Aids